Hope S. Rugo

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Hope S. Rugo
Mar 4, 2025, 12:06 | Blog
Nicholas Hornstein: Results for CRC liver metastasis from the COLLISION trial
Nicholas Hornstein, Hematologist and Oncologist with Northwell Health, shared an article Susan van der Lei…
Mar 4, 2025, 11:14 | Blog
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research…
Jan 4, 2025, 15:18 | Insight
Vivek Subbiah: Top Phase 1 clinical trial publications of 2024
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 28, 2024, 15:46 | Drugs
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 27, 2024, 10:48 | Drugs
Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…
Dec 10, 2024, 16:07 | Opinion
Breast Cancer Research Digest by Dana-Farber Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Here’s the Breast Cancer Research Digest - a…
Sep 9, 2024, 11:46 | Insight
Association between TIL and survival in patients with MBC receiving first-line chemotherapy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a paper by Daniel Stover…
Aug 2, 2024, 01:47 | Blog
Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 25, 2024, 03:18 | Insight
6th and 7th ABC international consensus guidelines for the management of advanced breast cancer
ABC Global Alliance shared on LinkedIn: “Inequalities in access to care are a major hurdle…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 14, 2024, 22:09 | Blog
Maggie Cheang: Intrinsic subtypes with survival outcomes on CDK4/6 inhibitors
Maggie Cheang, Team Leader of Genomic Analysis - Clinical Trials at The Institute of Cancer Research,…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 22, 2024, 00:42 | Blog
Results from AMEERA-5 published in Journal of Clinical Oncology
Paolo Tarantino shared a post on X: "Results from AMEERA-5 published in Journal of Clinical Oncology.…
Jun 12, 2024, 07:37 | Blog
Hope S. Rugo on Breast Cancer Research 'Lessons from the Past Will Shape the Future' - Media Medic
Media Medic posted on LinkedIn: "At the 2024 ESMO BC conference, Professor Hope S. Rugo,…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Apr 29, 2024, 14:18 | Drugs
Matthew Goetz: Abemacicib in high risk ER+/HER2 negative breast cancer
Matthew Goetz, Professor of Oncology and Pharmacology at Mayo Clinic, shared on LinkedIn: “An important…
All: 17 Posts: 1 - 100
Special Coverage